The most valuable companies in the world aren’t on any stock exchange. Not yet.
The first company to connect the human brain
to a computer – and commercialise it.
Three products in development. Two FDA Breakthrough designations, 12 patients implanted. Neuralink isn’t a research product – it’s a platform company targeting a $100B+ market with no competitor at scale.
Mind Meets Machine
12 implants, 4 countries, 15,000+ hours of use. Patients controlling devices with thought alone – no other BCI company is close.
FDA Fast-Tracked
Two Breakthrough Device Designations from the FDA – for vision restoration and speech recovery.
First Mover in a $30B Market
Three products in development. 1.2B+ raised. A vertically integrated platform from chip to surgical robot. Neuralink owns the technology, the data, and the head start.
- ARK Venture Fund
Neuralink is the world leader in brain-computer interfaces – 12 human implants across 4 countries, two FDA Breakthrough Device designations, and a $9B valuation backed by Founders Fund, Sequoia, ARK Invest, and QIA.
FloatX gives you access to pre-IPO allocations before the window closes.